PK/PD modeling predicts robust target engagement and low probability of grade 4 hematological toxicity at recommended phase 2 starting dose of VX-970 in combination with carboplatin (AUC=5)
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS（2016）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要